UTERINE CORPUS LEIOMYOSARCOMA

Clinical trials for UTERINE CORPUS LEIOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new UTERINE CORPUS LEIOMYOSARCOMA trials appear

Sign up with your email to follow new studies for UTERINE CORPUS LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo aims to halt aggressive uterine cancer

Disease control Ongoing

This study is testing whether combining two drugs, olaparib and temozolomide, can help control advanced uterine leiomyosarcoma, a rare and aggressive cancer. It is for patients whose cancer has spread or cannot be removed by surgery and who have already tried at least one other t…

Matched conditions: UTERINE CORPUS LEIOMYOSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

UTERINE CORPUS LEIOMYOSARCOMA

Get alerted when new UTERINE CORPUS LEIOMYOSARCOMA trials appear

New drug duo aims to halt aggressive uterine cancer